4',6-dihydroxyflavone has been researched along with isoliquiritigenin in 1 studies
| Studies (4',6-dihydroxyflavone) | Trials (4',6-dihydroxyflavone) | Recent Studies (post-2010) (4',6-dihydroxyflavone) | Studies (isoliquiritigenin) | Trials (isoliquiritigenin) | Recent Studies (post-2010) (isoliquiritigenin) |
|---|---|---|---|---|---|
| 10 | 0 | 3 | 472 | 2 | 324 |
| Protein | Taxonomy | 4',6-dihydroxyflavone (IC50) | isoliquiritigenin (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 1.87 | |
| Interstitial collagenase | Homo sapiens (human) | 0.016 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.269 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.01 | |
| Stromelysin-1 | Homo sapiens (human) | 0.081 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.269 | |
| Matrilysin | Homo sapiens (human) | 0.008 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.269 | |
| Aromatase | Homo sapiens (human) | 3.8 | |
| 17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | 2.83 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.01 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.32 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 4.88 | |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | 0.36 | |
| Collagenase 3 | Homo sapiens (human) | 0.014 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.269 | |
| NACHT, LRR and PYD domains-containing protein 3 | Homo sapiens (human) | 1.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavande, N; Hanrahan, JR; Hibbs, DE; Kim, MS; Matin, A; Roubin, RH; Salam, NK; Yang, NX | 1 |
1 other study(ies) available for 4',6-dihydroxyflavone and isoliquiritigenin
| Article | Year |
|---|---|
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Topics: Benzopyrans; Cell Line; Humans; PPAR alpha; PPAR gamma; Structure-Activity Relationship | 2009 |